These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23055705)

  • 1. New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia.
    Kung FC; Ishii R; Liu HC; Takeda M
    Clin Interv Aging; 2012; 7():393-6. PubMed ID: 23055705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.
    Mizukami K; Asada T; Kinoshita T; Tanaka K; Sonohara K; Nakai R; Yamaguchi K; Hanyu H; Kanaya K; Takao T; Okada M; Kudo S; Kotoku H; Iwakiri M; Kurita H; Miyamura T; Kawasaki Y; Omori K; Shiozaki K; Odawara T; Suzuki T; Yamada S; Nakamura Y; Toba K
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):191-9. PubMed ID: 19079814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial.
    Nagata K; Yokoyama E; Yamazaki T; Takano D; Maeda T; Takahashi S; Terayama Y
    Phytomedicine; 2012 Apr; 19(6):524-8. PubMed ID: 22421528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease.
    Furukawa K; Tomita N; Uematsu D; Okahara K; Shimada H; Ikeda M; Matsui T; Kozaki K; Fujii M; Ogawa T; Umegaki H; Urakami K; Nomura H; Kobayashi N; Nakanishi A; Washimi Y; Yonezawa H; Takahashi S; Kubota M; Wakutani Y; Ito D; Sasaki T; Matsubara E; Une K; Ishiki A; Yahagi Y; Shoji M; Sato H; Terayama Y; Kuzuya M; Araki N; Kodama M; Yamaguchi T; Arai H
    Geriatr Gerontol Int; 2017 Feb; 17(2):211-218. PubMed ID: 26711658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia.
    Kawanabe T; Yoritaka A; Shimura H; Oizumi H; Tanaka S; Hattori N
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):284-7. PubMed ID: 19948198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
    Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
    J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
    Matsunaga S; Kishi T; Iwata N
    J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine.
    Iwasaki K; Kosaka K; Mori H; Okitsu R; Furukawa K; Manabe Y; Yoshita M; Kanamori A; Ito N; Wada K; Kitayama M; Horiguchi J; Yamaguchi S; Takayama S; Fukuhara R; Ouma S; Nakano S; Hashimoto M; Kinoshita T
    Psychogeriatrics; 2012 Dec; 12(4):235-41. PubMed ID: 23279145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.
    Okahara K; Ishida Y; Hayashi Y; Inoue T; Tsuruta K; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Yoshida K; Noda S; Tomita S; Fujimoto M; Hosomi J; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):532-6. PubMed ID: 20170698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats.
    Ikarashi Y; Iizuka S; Imamura S; Yamaguchi T; Sekiguchi K; Kanno H; Kawakami Z; Yuzurihara M; Kase Y; Takeda S
    Biol Pharm Bull; 2009 Oct; 32(10):1701-9. PubMed ID: 19801831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open label trial to evaluate the efficacy and safety of Yokukansan, a traditional Asian medicine, in dementia with Lewy bodies.
    Iwasaki K; Kosaka K; Mori H; Okitsu R; Furukawa K; Manabe Y; Yoshita M; Kanamori A; Ito N; Wada K; Kitayama M; Horiguchi J; Yamaguchi S; Fukuhara R; Ouma S; Nakano S; Hashimoto M; Kinoshita T
    J Am Geriatr Soc; 2011 May; 59(5):936-8. PubMed ID: 21568966
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.
    Iwasaki K; Satoh-Nakagawa T; Maruyama M; Monma Y; Nemoto M; Tomita N; Tanji H; Fujiwara H; Seki T; Fujii M; Arai H; Sasaki H
    J Clin Psychiatry; 2005 Feb; 66(2):248-52. PubMed ID: 15705012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycyrrhiza and Uncaria Hook contribute to protective effect of traditional Japanese medicine yokukansan against amyloid β oligomer-induced neuronal death.
    Kanno H; Kawakami Z; Iizuka S; Tabuchi M; Mizoguchi K; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2013 Aug; 149(1):360-70. PubMed ID: 23838475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence.
    Matsumoto K; Zhao Q; Niu Y; Fujiwara H; Tanaka K; Sasaki-Hamada S; Oka J
    J Pharmacol Sci; 2013; 122(4):257-69. PubMed ID: 23883485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
    Hayashi Y; Ishida Y; Inoue T; Udagawa M; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Sameshima T; Kawahara T; Goto I; Shudo K; Kurayama S; Nakamura J; Okahara K; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):541-5. PubMed ID: 20184936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients.
    Ikarashi Y; Mizoguchi K
    Pharmacol Ther; 2016 Oct; 166():84-95. PubMed ID: 27373856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the traditional Japanese Kampo medicine Yokukansan for chronic migraine: A case report.
    Akiyama H; Hasegawa Y
    Medicine (Baltimore); 2019 Sep; 98(36):e17000. PubMed ID: 31490382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural and psychological symptoms of dementia in an Alzheimer's disease case successfully treated with natural medicine: association with gonadotropins.
    Niitsu T; Okamoto H; Iyo M
    Psychogeriatrics; 2013 Jun; 13(2):124-7. PubMed ID: 23909971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yokukansan, a kampo medicine, protects against glutamate cytotoxicity due to oxidative stress in PC12 cells.
    Kawakami Z; Kanno H; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2011 Mar; 134(1):74-81. PubMed ID: 21130853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.